Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=974e39ae-74c2-493c-8bf5-817de203a255 Date 9/12/2014 Company Name ProcessUnity Mailing Address 33 Bradford Street Concord, MA 01742 USA Company Description ProcessUnity is a leading provider of cloud-based applications for risk management and service delivery management. The company’s software as a service (SaaS) platform gives organizations the control to assess, measure, and mitigate risk and to … Continue reading “ProcessUnity Garners $3,000,000 New Financing”
Category: Boston
ShopAdvisor Secures $1,414,999 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=448caf0d-36b1-4a8a-9fd4-8dd9bc9c9a25 Date 9/12/2014 Company Name ShopAdvisor Mailing Address 9 Damon Mill Square Concord, MA 01742 USA Company Description The ShopAdvisor deferred purchasing platform generates revenue for media publishers, bloggers, retailers & brands by helping consumers remember and follow through on their shopping interests when the time is right. Website http://www.shopadvisor.com Transaction Type … Continue reading “ShopAdvisor Secures $1,414,999 New Funding”
Boston Security Firms CyberArk, Veracode Make Deals as Threats Mount
Been hacked lately? Sure you have. But a couple of longstanding local tech companies have been combating cyber threats for years, and now they’re making noise on the financial front. One of them, CyberArk Software, has been preparing to go public since about 2011 and has just set its IPO terms. The Israel-founded company, whose … Continue reading “Boston Security Firms CyberArk, Veracode Make Deals as Threats Mount”
Hear Epizyme, Sage, Zafgen Share Their Stories on Oct. 8
Like many biotechs with a big idea showing early potential, Cambridge, MA-based Epizyme (NASDAQ: [[ticker:EPZM]]) faced a critical decision a few years ago: groom itself for a sale to Big Pharma or, on the other hand, an IPO. It was a tough call for Epizyme, because the IPO market for biotechs was in the dumps … Continue reading “Hear Epizyme, Sage, Zafgen Share Their Stories on Oct. 8”
Veracode Secures $39,999,983 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c8d46d3d-a12c-4174-bbdb-190610ddd297 Date 9/11/2014 Company Name Veracode Mailing Address 65 Network Drive Burlington, MA 01803 USA Company Description Veracode is the industry’s first provider of automated, on-demand application security solutions. Created by a world-class team of application security experts from @stake, Guardent, ISS, VeriSign and Symantec, the company delivers services to identify software … Continue reading “Veracode Secures $39,999,983 New Funding Round”
OneView Commerce Obtains $1,521,352 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c62ab86d-3527-42c4-af80-f2fb95c93763 Date 9/11/2014 Company Name OneView Commerce Mailing Address 70 Fargo St. Boston, MA 02210 USA Company Description The key differentiators at OneView Commerce are a SOA-based, process-driven application design that gives the retailer complete control over the configuration and business flow of the solution and the depth of our management team … Continue reading “OneView Commerce Obtains $1,521,352 New Round”
The Knowledge Worker’s Next Must-Have Gadget: A Telepresence Robot
If robotics startups get it right, the next piece of hardware you expense to your company may be a telepresence robot, a pedestal-shaped machine that will let you scoot around a remote office to check in on colleagues. Robots are already used in factories, warehouses, and to vacuum people’s floors, but they have yet to … Continue reading “The Knowledge Worker’s Next Must-Have Gadget: A Telepresence Robot”
Xconomy Forum: Tech Agenda 2015
The calendar is running out fast on 2014 and if you’re like us, your head is probably swimming with big ideas, bold claims, and plain old information overload. Want to find out what’s really going on? Join Xconomy for Tech Agenda 2015, our in-depth look at the real forces driving change in technology, business, and … Continue reading “Xconomy Forum: Tech Agenda 2015”
Pappas, Chiesi Venture Fund Joins Ranks of Pharma & VC Partnerships
Art Pappas has overseen his own firm’s venture capital investments for 20 years. Now the veteran life sciences investor is adding on a new role, scoping out investment opportunities for a pharmaceutical company’s new venture fund. Italian pharma Chiesi Group’s recently-launched Chiesi Ventures will focus on investing in companies developing treatments for rare and orphan … Continue reading “Pappas, Chiesi Venture Fund Joins Ranks of Pharma & VC Partnerships”
An Intriguing Program Takes on Tropical Diseases—But Not Ebola
[Updated and corrected 9/10/14, 10:05 am. See below.] On August 28, Anthony Fauci, the U.S. National Institutes of Health’s top infectious disease specialist, announced a major trial in concert with GlaxoSmithKline (NYSE: [[ticker:GSK]]) to test new Ebola vaccines in humans. Fauci called it an “all-hands-on-deck response” to the growing global health emergency in which more … Continue reading “An Intriguing Program Takes on Tropical Diseases—But Not Ebola”
OnKol Wants to Help Grandma Join the Internet of Things Movement
As investors and corporations pour millions of dollars into connected-home devices, tech companies have no shortage of ideas—from smart thermostats and home security systems to data-collecting toothbrushes and a refrigerator that sends alerts when the milk is almost out. But while most of these “Internet of things” products are aimed at young tech-savvy adults or … Continue reading “OnKol Wants to Help Grandma Join the Internet of Things Movement”
Persimmon Technologies Garners $1,176,394 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e4635b7c-7d37-4fca-9aa6-3b49591afb6b Date 9/10/2014 Company Name Persimmon Technologies Mailing Address 200 Harvard Mill Square Wakefield, MA 01880 USA Company Description Persimmon’s vision is to build the largest vacuum robotics company serving the Semiconductor, LED and Solar markets by 2020 in addition to growing Nidec Sankyo’s atmospheric robot business to the top market position … Continue reading “Persimmon Technologies Garners $1,176,394 New Funding Round”
Xconomy Q&A: Intellectual Ventures Co-founder and CTO Edward Jung
Edward Jung, co-founder and chief technology officer, of Intellectual Ventures, has been out talking about how his company—which was recently described as among Silicon Valley’s most hated—is playing a long game to attack the big problems confronting the world today. On the sidelines of the Boao Forum for Asia in Seattle last week, Jung sat … Continue reading “Xconomy Q&A: Intellectual Ventures Co-founder and CTO Edward Jung”
RunKeeper Sees Apple Health Moves as “Both Scary and Exciting”
If you’re an independent mobile developer, big Apple product announcements are more than just a passing curiosity—entire companies can be dramatically boosted or quickly crippled by the huge company’s decisions. One of those watching the developments closely was Jason Jacobs, the CEO of fitness-tracking startup RunKeeper. And he had plenty to digest. Jacobs’ Boston-based company, … Continue reading “RunKeeper Sees Apple Health Moves as “Both Scary and Exciting””
As New iPhone Looms, Mobile Payments “Not for the Faint of Heart”
Heard of the iPhone 6 yet? One of the rumored features is near field communication technology that will enable, among other things, users to pay for items in stores with their smartphones. It could be a watershed moment for the adoption of mobile payments technology, a crowded yet slow-moving sector. Every year since about 2010, … Continue reading “As New iPhone Looms, Mobile Payments “Not for the Faint of Heart””
To Fight Cramps, Christoph Westphal Taps Boston All-Stars for $40M
Serial biotech executive Christoph Westphal looks to have found his latest target: muscle cramps. Westphal, perhaps best known as the one-time CEO of Sirtris Pharmaceuticals, is now chairman and CEO of a new startup called Flex Pharma. He’s gone through the rolodex to put together $40 million in private financing from a diverse list of … Continue reading “To Fight Cramps, Christoph Westphal Taps Boston All-Stars for $40M”
The Healthcare Summit 2014
The healthcare transformation is in full swing. Though the ultimate payoffs, namely better care and better economics, have yet to be realized, the building blocks are quickly falling into place: increasingly sophisticated data and analysis tools in the hands of researchers and physicians, powerful healthcare apps and wearable devices in the hands of consumers, and … Continue reading “The Healthcare Summit 2014”
Wellframe Wins $8.5M to Improve Healthcare Apps for Patients, Doctors
Healthcare is getting more personal—as well it should. Anyone who has dealt with a serious illness knows you have to take the initiative when it comes to your own health, and that of your family. Especially these days. Technology is playing a big role in that. So it’s no surprise that a new generation of … Continue reading “Wellframe Wins $8.5M to Improve Healthcare Apps for Patients, Doctors”
Y Combinator Alum Lob Raises $7M to Expand APIs for Print Marketing
A lot of the fun in our current Internet era comes from the ability to manipulate the “real” world with digital tools—arranging a ride, ordering some food, or changing the temperature in your house when nobody’s home. Lob, a San Francisco-based startup, is hoping to add an international network of print shops to that list. … Continue reading “Y Combinator Alum Lob Raises $7M to Expand APIs for Print Marketing”
Skyword Secures $11,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c8b13307-979a-4fea-ad26-3547e6dbab81 Date 9/8/2014 Company Name Skyword Mailing Address 25 Thomson Place Boston, MA 02110 USA Company Description Skyword is the leader in Search-Driven Media (SDM). Skyword enables brands to acquire and engage customers through efficient forecasting, creation and placement of brand-aligned content that precisely matches consumer search. Clients include Proctor & Gamble, … Continue reading “Skyword Secures $11,000,000 New Funding”
Intigua Obtains $2,000,000 Series B Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=58308188-8d89-4ede-bddd-54e35b79a663 Date 9/8/2014 Company Name Intigua Mailing Address 199 Wells Ave Newton, MA 02459 USA Company Description Intigua virtualizes the management layer, bringing cloud-grade scalability and agility to infrastructure monitoring and management for the first time. Website http://www.intigua.com Transaction Type Venture Equity Transaction Amount $2,000,000 Transaction Round Series B Proceeds Purposes Proceeds … Continue reading “Intigua Obtains $2,000,000 Series B Financing”
Wellframe Lands $8,500,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=db8260d8-98ae-40ff-a9a6-9586ce394840 Date 9/8/2014 Company Name Wellframe Mailing Address 745 Atlantic Avenue Boston, MA 02111 USA Company Description We are using mobile technology and artificial intelligence to translate clinical protocols into personalized, adaptive to-do lists, made available to patients from their mobile device and ensconced in a vigilant system. We are building a … Continue reading “Wellframe Lands $8,500,000 New Funding Round”
Flex Pharma Obtains $40,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=74bf225a-5a71-4a11-9bcb-c804a4d763ff Date 9/8/2014 Company Name Flex Pharma Mailing Address 800 Boylston St. 24th Floor Boston, MA 02199 USA Company Description Most muscle cramps are not caused by dehydration, lactic acid, electrolyte imbalance, or muscle tightness. That is why popular remedies like sports drinks, bananas, magnesium tablets, and stretching are usually ineffective. Flex … Continue reading “Flex Pharma Obtains $40,000,000 New Financing Round”
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief
John Maraganore opened up an envelope in 1994 that changed his life. Inside were the results of the pivotal study of an anticoagulant drug Maraganore had created in the lab. It was the star prospect for Maraganore’s employer, Biogen. If the drug, bivalirudin, worked, Biogen might have its first product—and Maraganore, the glory of designing … Continue reading “John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief”
Innovation Hub: John Maeda on Why Tech Loves Design
John Maeda stands at the intersection of design and technology—and attracts a bit of a cult following. He’s the first Design Partner at Kleiner Perkins, the venture capital firm that has backed companies from Amazon to Genentech to WebMD. Previously, he served as President of The Rhode Island School of Design. Maeda insists that design … Continue reading “Innovation Hub: John Maeda on Why Tech Loves Design”
East Coast Biotech Roundup: Infinity, Merck, Voyager, Ebola, & More
There are always surprises—both good and bad—in a volatile sector like biotech. A big deal can seemingly come out of nowhere, for instance, and send a company’s stock flying. That was the top story in East Coast biotech this week, but we’ve got all the other tidbits you might have missed, including a few additional … Continue reading “East Coast Biotech Roundup: Infinity, Merck, Voyager, Ebola, & More”
Boston Tech Roundup: Savant, Black Duck, LogMeIn, Mobiquity, Bridj
Here’s a smattering of fundraising deals from recent days around the greater Boston area, and an acquisition thrown in for good measure: —Savant Systems, an established home-automation company based in Hyannis, MA, has raised $90 million from private equity firm KKR and Savant’s founder, Robert Madonna. The company, founded in 2005, makes smart-home systems for the luxury market. … Continue reading “Boston Tech Roundup: Savant, Black Duck, LogMeIn, Mobiquity, Bridj”
iSpecimen Garners $8,000,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4ecd9ecf-818b-4327-ba64-249671ade46b Date 9/5/2014 Company Name iSpecimen Mailing Address 450 Bedford Street Lexington, MA 02420 USA Company Description iSpecimen is a supplier of human clinical specimens to the therapeutic, diagnostic and academic research industries. Our mission is to make it easy for medical researchers to access liquid and solid clinical lab specimens. We … Continue reading “iSpecimen Garners $8,000,000 Series B Funding”
Cignifi Obtains Series A-2 Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b2d0e929-a8a1-4c97-85da-2fe922f97028 Date 9/5/2014 Company Name Cignifi Mailing Address 101 Main St. 14th Floor Cambridge, MA 02142 USA Company Description Cignifi is revolutionizing the way financial service companies meet the needs of 2.7 billion people worldwide with a mobile phone but no access to formal financial services. The company has developed the first … Continue reading “Cignifi Obtains Series A-2 Funding”
Wallflowr Lands $365,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=179735ed-3040-41ab-a6da-60d78298fa20 Date 9/5/2014 Company Name Wallflowr Mailing Address 1 Broadway Cambridge, MA 02142 USA Company Description Wallflowr is a company working on developing technologies for a safer home and work environment. Wallflowr has a patent-pending system to detect the proximity of people and advanced control of appliances and devices. Website http://www.wallflowr.com Transaction … Continue reading “Wallflowr Lands $365,000 New Round”
Veracyte Acquires Allegro Diagnostics for $21,000,000
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c98d55ea-81e4-468a-9532-813d0be5e579 Date 9/5/2014 Company Name Allegro Diagnostics Mailing Address 6 Clock Tower Place Maynard, MA 01754 USA Company Description Allegro Diagnostics is a leader in the field of gene expression molecular diagnostic testing for lung cancer and other diseases. Website http://www.allegrodx.com Transaction Type M&A Transaction Amount $21,000,000 Transaction Round Proceeds Purposes M&A … Continue reading “Veracyte Acquires Allegro Diagnostics for $21,000,000”
Bridj Secures $4,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b56b8ce2-097d-4b12-8949-d0c77843eb34 Date 9/5/2014 Company Name Bridj Mailing Address 101 Main Street 4th Floor Cambridge, MA 02142 USA Company Description Bridj uses big data and crowdsourcing to predict how a city moves. It then deploys a dynamic transportation network of direct shuttles to match popular origin and destination pairings. Website http://www.bridj.com Transaction Type … Continue reading “Bridj Secures $4,000,000 New Funding”
What Tesla’s Gigafactory Means for Battery Startups
The most exciting news of the year in electric vehicles came today with the announcement that Tesla Motors will build its giant lithium ion battery factory in Nevada. It’s a huge vote of confidence in the future of EVs, but at the same time it points to the long road startups face getting their novel battery … Continue reading “What Tesla’s Gigafactory Means for Battery Startups”
Techstars to Offer “Equity Back Guarantee” to Skeptical Startups
Techstars is making a new pitch to entrepreneurs—satisfaction guaranteed, or your equity back. The startup accelerator, based in Boulder, CO, invests $18,000 in its startups in exchange for 6 percent of their equity. Techstars also offers each startup a $100,000 convertible note, which can increase its share of the company to 10 percent. But beginning … Continue reading “Techstars to Offer “Equity Back Guarantee” to Skeptical Startups”
Merck, Leapfrogging Bristol-Myers, Wins FDA Nod for Cancer Drug
It wasn’t too long ago that Merck (NYSE: [[ticker:MRK]]) was well behind Bristol-Myers Squibb (NYSE: [[ticker:BMY]]) in the race to bring the first so-called PD-1 inhibitor—a new class of cancer drugs that harness the power of the immune system—to market in the U.S. While the battle between these two companies over market share will likely … Continue reading “Merck, Leapfrogging Bristol-Myers, Wins FDA Nod for Cancer Drug”
Fractyl Laboratories Obtains $19,764,908 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c4008306-25ba-4802-866f-619b45821675 Date 9/4/2014 Company Name Fractyl Laboratories Mailing Address 203 Crescent St. Waltham, MA 02453 USA Company Description To liberate patients, empower physicians, and lower health care costs by developing device-based solutions to chronic diseases. Website http://www.fractyl.com Transaction Type Venture Equity Transaction Amount $19,764,908 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were … Continue reading “Fractyl Laboratories Obtains $19,764,908 New Funding”
Savant Systems Secures $90,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4bc23f48-6b8b-4c96-bc2f-9af5d22fee07 Date 9/4/2014 Company Name Savant Systems Mailing Address 45 Perseverance Way Hyannis, MA 02601 USA Company Description Savant Systems, LLC designs, develops and manufactures a complete suite of software and hardware solutions for the connected home and control applications. Website http://www.savantsystems.com Transaction Type Venture Equity Transaction Amount $90,000,000 Transaction Round Undisclosed … Continue reading “Savant Systems Secures $90,000,000 New Funding Round”
Google’s Calico Nabs First Partner, Cuts $1.5B R&D Deal With AbbVie
[Updated, 9/4/14, 8:25 am ET] It’s still a public mystery what Google’s (NASDAQ: [[ticker:GOOG]]) high-profile anti-aging startup, Calico, is really up to. But the drug company AbbVie has had a peek behind the curtain and is ready to throw a whole lot of cash behind the company’s high-profile team in a deal to develop medicines … Continue reading “Google’s Calico Nabs First Partner, Cuts $1.5B R&D Deal With AbbVie”
Oasys Loves That Dirty Water From Fracking and Now, Coal Plants
Everyone knows there’s a need for technologies to make fresh water safe for drinking. But Oasys Water has found the strongest demand for its technology comes from treating some of the nastiest water around, particularly wastewater associated with fossil fuels. On Tuesday, the Boston-based company said its forward-osmosis water purification system will be used at … Continue reading “Oasys Loves That Dirty Water From Fracking and Now, Coal Plants”
Steven Paul, Former Lilly R&D Chief, Takes Head Seat at Voyager
Steven Paul stepped in to Third Rock Ventures a few years ago to help advise on some of the firm’s biotech startups. Now, however, it appears Eli Lilly’s former R&D chief has found one he likes enough to lead full-time. Cambridge, MA-based Voyager Therapeutics announced today that Paul has agreed to take over as its … Continue reading “Steven Paul, Former Lilly R&D Chief, Takes Head Seat at Voyager”
AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug
It’s been a topsy-turvy few years for Infinity Pharmaceuticals. The Cambridge, MA-based company is well behind a few others, whose rival blood cancer drugs that have already made it to market, and Infinity has seen its shares rise and fall as investors have wondered whether its own prospect—known as duvelisib, or IPI-145—can stand out. Pharma … Continue reading “AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug”
Black Duck Software Secures $20,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5a441f98-e0f8-477b-bcaa-935b0b15a914 Date 9/3/2014 Company Name Black Duck Software Mailing Address 8 New England Executive Park Burlington, MA 01803 USA Company Description Black Duck Software is the leading provider of products and services for automating the management, governance and secure use of open source software in multi-source development at enterprise scale. Website http://www.blackducksoftware.com … Continue reading “Black Duck Software Secures $20,000,000 New Round”
Superpedestrian Lands $4,074,990 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1e93ede6-cbbb-40ff-8b40-b2ea3da6c0d3 Date 9/3/2014 Company Name Superpedestrian Mailing Address 84 Hamilton Street Cambridge, MA 02139 USA Company Description Superpedestrian brings together a team of designers and engineers with one vision: transforming urban mobility. Our first idea? Pedal power. With an exclusive license of MIT’s Copenhagen Wheel, we are now working round the clock … Continue reading “Superpedestrian Lands $4,074,990 New Financing Round”
Compuware Goes Private in $2.5B Deal, Seeks Flexibility in Tech Wars
Compuware announced today that it has been purchased by Thoma Bravo, a private equity firm with offices in San Francisco and Chicago, for $2.5 billion. Under the terms of the agreement, Compuware shareholders will receive $10.92 per share, a 17 percent increase over the company’s closing stock price on Friday. Compuware’s board has approved the … Continue reading “Compuware Goes Private in $2.5B Deal, Seeks Flexibility in Tech Wars”
Exelixis Axes 70% of Workforce as Cancer Drug Flops, Shares Routed
When Exelixis won FDA approval of a drug called cabozantinib in 2012, it was supposed to represent the first step towards a franchise. The South San Francisco-based company’s drug was approved to treat a small group of patients with a certain form of thyroid cancer, but its big opportunity lay further ahead, in big studies … Continue reading “Exelixis Axes 70% of Workforce as Cancer Drug Flops, Shares Routed”
TranscribeMe, Nuance Fine-Tuning Audio Transcription For Hot Market
In 1999, the futurist and speech recognition technology pioneer Ray Kurzweil predicted that by 2009, deafness would be a mere inconvenience rather than a disability. That’s because deaf people would be carrying small machines that would listen to their companions and display real-time text transcripts of their conversations, Kurzweil imagined in his book The Age … Continue reading “TranscribeMe, Nuance Fine-Tuning Audio Transcription For Hot Market”
Which Countries Excel in Creating New Drugs? It’s Complicated
A lot has been written lately about innovation, or the lack thereof, in the world of biopharma. One question that often gets asked: which countries lead the way in creating new medicines? Many people think that drugs originate in the nation where the companies that produce them are headquartered. The truth, however, is much more … Continue reading “Which Countries Excel in Creating New Drugs? It’s Complicated”
FINSix Wants You to Ditch Laptop “Brick” for Its Small, Stylish Adapter
Some emerging technologies first come to market in business-to-business applications—LED lights, for example, took hold in TVs before consumer bulbs. Hardware startup FINSix has found the opposite to be true: its initial product will be squarely aimed at consumers, thanks in large part to a successful Kickstarter campaign. Early next year, the company plans to … Continue reading “FINSix Wants You to Ditch Laptop “Brick” for Its Small, Stylish Adapter”
Neurovance Garners $4,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d8a97f4b-bcd9-413c-966b-a09ff86407ae Date 9/2/2014 Company Name Neurovance Mailing Address 43 Thorndike Street Cambridge, MA 02141 USA Company Description Neurovance is a clinical stage neuroscience-focused company. Following development of centanafadine SR (formerly EB-1020 SR) for adult ADHD, Neurovance will develop centanafadine SR for adolescent and pediatric ADHD. Website http://www.neurovance.com Transaction Type Venture Equity Transaction … Continue reading “Neurovance Garners $4,000,000 New Financing”
NABsys Secures $25,500,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=31d8d1a8-7601-466d-a3d9-cd11cc5968f7 Date 9/2/2014 Company Name NABsys Mailing Address 60 Clifford St. Providence, RI 02903 USA Company Description NABsys aims to make whole-genome DNA sequencing fast, inexpensive, and accurate enough to be used in clinical care. Website http://www.nabsys.com Transaction Type Venture Equity Transaction Amount $25,500,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were … Continue reading “NABsys Secures $25,500,000 New Funding”